Home / Page /
International Molecular Diagnostics Congress, 2016 | Unlocking Personalized Medicine through Molecular Diagnostics: Personalized medicine remains an area of huge opportunities and promise for diagnostics companies, but capturing the real value will require a disruption of the current reimbursement and delivery model.

International Molecular Diagnostics Congress, 2016

Loading Events

« All Events

  • This event has passed.

International Molecular Diagnostics Congress, 2016

September 13, 2016 - September 15, 2016

International Molecular Diagnostics Congress, 2016 | Unlocking Personalized Medicine through Molecular Diagnostics: Personalized medicine remains an area of huge opportunities and promise for diagnostics companies, but capturing the real value will require a disruption of the current reimbursement and delivery model.

International Molecular Diagnostics Congress, 2016 | Unlocking Personalized Medicine through Molecular Diagnostics: Personalized medicine remains an area of huge opportunities and promise for diagnostics companies, but capturing the real value will require a disruption of the current reimbursement and delivery model. To enhance your fair share of value in this huge market Genetic InsidER organizes the first commercially focused congress for Molecular Diagnostics stakeholders.

The opportunity is sizeable: +8,000 monogenic genetic diseases, as well as many cancers caused by the combination of certain mutations with any number of undefined environmental factors would be diagnosed and treated more appropriately and faster with personalized medicine. This market has made $1tn in 2014 and forecasts expect to double it for 2022 with $2.5tn, it’s time to face up the challenges.

International Molecular Diagnostics Congress, 2016 | Unlocking Personalized Medicine through Molecular Diagnostics

Special discount for BioChem Adda Readers: Use the code “biochemvipaccess200” to get a €200 discount at the ticket to attend!

In this congress you’ll learn about:

– Latest developments and trends in diagnostics technologies in the personalized medicine industry

– Disruptive and sustainable business models to capture value for Diagnostics

– Understanding how to increase physician awareness and demand

– Regulatory frameworks 2.0 – The keys to Market Access

– The key to American Market Access for European companies

– Demonstrate the value of diagnostic technologies to secure coverage and payment

– Clarify the uncertainty on reimbursement and managing stakeholder

Half of all pharma companies are already integrating personalized medicine in their future strategy and business models; become part of the health care disruption by enshrining its mission in the very DNA of your company to bullet proof your strategy today.

Don’t miss out the first commercially focused congress for the companion diagnostics industry! The brochure has all the information you need regarding speakers, agenda, ticket prices and many other details about the congress. Now it’s available to download, get it today here in 10 seconds: www.genetic-insider.com/diagnostics/brochure

Details

Start:
September 13, 2016
End:
September 15, 2016
Website:
http://genetic-insider.com/diagnostics/

Organizer

Genetic Insider
Phone:
+34 954 215170
Email:
araceli@genetic-insider.com
Website:
http://genetic-insider.com/
BioChem Adda is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad-blocker.